ZAL, potential catalysts are US patents being granted and fast track designation. I think most investors are in a wait and watch mode. The NIH study results should be out at year end or early Q1. NIH finished the trial on time and just waiting for the data to be compiled and published.
One thing is for sure, if they saw any safety issues they would have stopped the trial.. The big IF will be efficacy.